VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AMPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AMPHAmphastar Pharmaceuticals, Inc.
$25.14$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMPHQuarterly Financials

Amphastar Pharmaceuticals, Inc. (AMPH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Amphastar Pharmaceuticals, Inc. (AMPH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AMPH Income Statement

Quarterly statement

AMPH Income Statement

Amphastar Pharmaceuticals, Inc. (AMPH) annual income statement — 14-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue183.9M171.17M183.1M191.84M174.41M170.53M186.52M188.82M182.39M171.84M178.1M180.56M145.71M140.02M135.02M120.13M123.47M120.37M120.89M112.2M
Revenue Growth %5.44%0.38%-1.83%1.6%-4.38%-0.76%4.73%4.58%25.17%22.72%31.91%50.3%18.02%16.33%11.69%7.07%21.45%16.84%26.03%34.48%
Cost of Goods Sold90.43M100.85M97.44M93.19M87.92M85.28M99.88M86.88M87.23M84.55M81.97M72.15M72.97M66.18M63.85M61.62M60.11M64.54M64.65M61.02M
COGS % of Revenue49.17%58.92%53.21%48.58%50.41%50.01%53.55%46.01%47.82%49.2%46.02%39.96%50.08%47.27%47.29%51.29%48.69%53.62%53.48%54.38%
Gross Profit93.47M70.32M85.67M98.65M86.49M85.25M86.65M101.94M95.17M87.29M96.14M108.4M72.74M73.84M71.17M58.51M63.36M55.83M56.23M51.18M
Gross Margin %50.83%41.08%46.79%51.42%49.59%49.99%46.45%53.99%52.18%50.8%53.98%60.04%49.92%52.73%52.71%48.71%51.31%46.38%46.52%45.62%
Gross Profit Growth %8.07%-17.51%-1.13%-3.23%-9.12%-2.34%-9.87%-5.96%30.83%18.22%35.09%85.27%14.81%32.27%26.56%14.32%33.73%24.21%52.68%40.2%
Operating Expenses53.74M56.69M50.06M73.33M44.31M47.96M41.5M44.89M39.95M39.28M42.16M35.73M35.84M40.41M33.34M35.28M38.53M34.21M31.98M26.41M
OpEx % of Revenue29.22%33.12%27.34%38.22%25.4%28.12%22.25%23.78%21.9%22.86%23.67%19.79%24.6%28.86%24.69%29.37%31.21%28.42%26.46%23.54%
Selling, General & Admin31.58M29.95M26.75M50.97M24.23M27.86M23.36M23.82M22.3M25.05M21.74M19.06M19M20.59M16.1M16.77M15.73M17.99M14.7M15.65M
SG&A % of Revenue17.17%17.5%14.61%26.57%13.89%16.34%12.53%12.61%12.22%14.58%12.21%10.56%13.04%14.71%11.92%13.96%12.74%14.95%12.16%13.95%
Research & Development22.16M26.74M23.31M22.35M20.08M20.1M18.14M21.08M17.65M14.23M20.42M16.66M16.84M19.82M17.24M18.51M22.8M16.22M17.29M10.76M
R&D % of Revenue12.05%15.62%12.73%11.65%11.51%11.78%9.73%11.16%9.68%8.28%11.46%9.23%11.56%14.15%12.77%15.41%18.46%13.48%14.3%9.59%
Other Operating Expenses00000000000000000000
Operating Income39.73M13.63M35.61M25.32M42.18M37.29M45.14M57.05M55.22M48.01M53.98M72.68M36.9M33.43M37.83M23.23M24.82M21.61M24.25M24.77M
Operating Margin %21.6%7.96%19.45%13.2%24.19%21.87%24.2%30.21%30.27%27.94%30.31%40.25%25.32%23.88%28.02%19.34%20.11%17.96%20.06%22.08%
Operating Income Growth %-5.82%-63.45%-21.13%-55.62%-23.6%-22.32%-16.37%-21.51%49.66%43.6%42.68%212.89%48.64%54.68%56%-6.22%135.07%109.72%742.38%604.26%
EBITDA45.2M30.12M51.59M39.45M58.42M52.5M59.81M71.48M69.36M61.97M67.77M86.25M43.92M40.83M45.27M30.55M31.65M28.41M30.8M31.28M
EBITDA Margin %24.58%17.6%28.18%20.56%33.5%30.79%32.06%37.86%38.03%36.07%38.05%47.77%30.14%29.16%33.52%25.43%25.64%23.6%25.48%27.88%
EBITDA Growth %-22.63%-42.62%-13.74%-44.81%-15.77%-15.29%-11.75%-17.12%57.94%51.79%49.71%182.29%38.75%43.72%46.95%-2.32%81.64%65.83%219.24%207.05%
D&A (Non-Cash Add-back)016.49M15.99M14.13M16.24M15.21M14.66M14.43M14.14M13.96M13.79M13.57M7.02M7.4M7.43M7.33M6.83M6.79M6.55M6.51M
EBIT45.2M16.61M38.54M27.8M45.62M37.15M50.39M54.38M58.85M55.91M50.8M77.34M36.41M33.97M41.79M23.16M23.55M29.39M27.33M38.17M
Net Interest Income-4.37M-4.15M-4.21M-4.04M-4.36M-4.2M-4.13M-4.27M-5.27M-6.05M-7.15M-12.5M-2.57M526K52K-235K-168K-174K-11K-386K
Interest Income2.29M2.4M2.42M2.25M1.92M2.09M2.29M2.43M3.34M2.56M2.3M1.2M1.03M924K580K331K229K181K157K141K
Interest Expense6.66M6.55M6.63M6.28M6.28M6.29M6.42M6.7M8.61M8.61M9.46M13.7M3.6M398K528K566K397K355K168K527K
Other Income/Expense-1.19M-3.58M-3.69M-3.81M-2.85M-6.43M-1.18M-9.37M-4.97M-707K-13.14M-9.43M-4.39M-649K3.37M-795K-1.93M6.72M2.7M12.88M
Pretax Income38.54M10.05M31.91M21.51M39.34M30.86M43.96M47.68M50.24M47.3M40.84M63.25M32.51M32.78M41.2M22.43M22.9M28.33M26.95M37.65M
Pretax Margin %20.96%5.87%17.43%11.21%22.55%18.1%23.57%25.25%27.55%27.53%22.93%35.03%22.31%23.41%30.52%18.67%18.55%23.54%22.3%33.55%
Income Tax8.2M3.63M7.49M4.16M8.3M5.58M6M7.25M12.29M4.13M4.67M14.03M6.38M6.75M7.29M6.56M5.55M4.08M7.19M6.69M
Effective Tax Rate %21.26%36.13%23.45%19.35%21.11%18.07%13.64%15.21%24.47%8.72%11.44%22.17%19.64%20.6%17.69%29.24%24.24%14.39%26.69%17.76%
Net Income30.35M6.42M24.43M17.35M31.03M25.29M37.96M40.43M37.95M43.18M36.17M49.22M26.12M26.03M33.91M15.87M17.35M24.25M19.76M29.55M
Net Margin %16.5%3.75%13.34%9.04%17.79%14.83%20.35%21.41%20.81%25.13%20.31%27.26%17.93%18.59%25.12%13.21%14.05%20.15%16.35%26.34%
Net Income Growth %-2.2%-74.61%-35.65%-57.09%-18.23%-41.44%4.97%-17.86%45.26%65.86%6.65%210.08%50.61%7.34%71.62%-46.28%123.33%381.11%415%653.97%
Net Income (Continuing)30.35M6.42M24.43M17.35M31.03M25.29M37.96M40.43M37.95M43.18M36.17M49.22M26.12M26.03M33.91M15.87M17.35M24.25M19.76M30.96M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.670.140.510.370.640.510.740.780.730.810.680.910.490.500.660.300.330.470.390.59
EPS Growth %4.69%-72.55%-31.08%-52.56%-12.33%-37.04%8.82%-14.29%48.98%62%3.03%203.33%48.48%6.38%69.23%-49.15%106.25%370%400%637.5%
EPS (Basic)0.690.140.530.380.660.530.780.830.780.900.751.010.540.540.700.320.350.500.410.62
Diluted Shares Outstanding44.23M46.46M47.16M47.68M48.13M49.89M52.06M51.86M52.05M53.01M53.01M53.92M53.1M51.97M51.72M52.79M53.23M51.98M50.06M50.01M
Basic Shares Outstanding43.64M45.32M45.91M46.47M46.95M47.64M48.43M48.62M48.91M48.21M47.96M48.7M48.4M48M48.3M48.9M48.86M48.14M47.84M48.02M
Dividend Payout Ratio--------------------